Storia in 5 fonti

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

Raccontata da

sabato 7 febbraio 2026·cnbc.com
US signals crackdown on compounded weight-loss drugs; Hims shares tumble
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.
sabato 7 febbraio 2026·ft.com
Hims & Hers abandons copycat weight-loss drug in face of FDA probe
Novo Nordisk had accused the telehealth company of breaching its patent on Wegovy

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

US signals crackdown on compounded weight-loss drugs; Hims shares tumble

Hims & Hers abandons copycat weight-loss drug in face of FDA probe

Hims & Hers pulls copycat weight-loss pill after threats of legal action

Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs